1. Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania.
- Author
-
Jornada LK, Valvassori SS, Steckert AV, Moretti M, Mina F, Ferreira CL, Arent CO, Dal-Pizzol F, and Quevedo J
- Subjects
- Analysis of Variance, Animals, Antimanic Agents pharmacology, Bipolar Disorder metabolism, Bipolar Disorder pathology, Brain drug effects, Brain enzymology, Brain pathology, Catalase metabolism, Disease Models, Animal, Drug Interactions, Gene Expression Regulation, Enzymologic drug effects, Injections, Intraventricular, Lithium Chloride pharmacology, Male, Protein Carbonylation drug effects, Rats, Rats, Wistar, Superoxide Dismutase metabolism, Thiobarbituric Acid Reactive Substances metabolism, Valproic Acid pharmacology, Antimanic Agents therapeutic use, Bipolar Disorder chemically induced, Bipolar Disorder drug therapy, Lithium Chloride therapeutic use, Ouabain adverse effects, Valproic Acid therapeutic use
- Abstract
In this study, we assessed the oxidative stress parameters in rats submitted to an animal model of mania induced by ouabain (OUA), which included the use of lithium (Li) and valproate (VPA). Li and VPA treatment reversed and prevented the OUA-induced damage in these structures, however, this effect varies depending on the brain region and treatment regimen. Moreover, the activity of the antioxidant enzymes, namely, superoxide dismutase (SOD) and catalase (CAT) was found to be increased and decreased, respectively, in the brain of OUA-administered rats. Li and VPA modulated SOD and CAT activities in OUA-subjected rats in both experimental models. Our results support the notion that Li and VPA exert antioxidant-like properties in the brain of rats submitted to animal model of mania induced by ouabain., (Copyright © 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF